Proteome Sciences Plc

Proteome Sciences Plc (PRM.- Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery, quality management and provision of data insights. The company detects and characterizes deferentially expressed proteins using its proprietary technologies in biological samples for prognostic, diagnostic and therapeutic applications. The company offers its services to pharmaceutical & biotechnology companies and academic research institution. It has research facility in Frankfurt, Germany and operates in the US, Germany and the UK through its subsidiaries. Proteome Sciences is headquartered in London, England, the UK.

Proteome Sciences Plc Key Recent Developments

Jan 21,2020: Proteome Sciences : Year end trading update
Oct 31,2019: Proteome Sciences: Trading update and announcement of Board Changes
Jan 23,2019: Proteome Sciences: Year end trading update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Proteome Sciences Plc - Key Facts
Proteome Sciences Plc - Key Employees
Proteome Sciences Plc - Key Employee Biographies
Proteome Sciences Plc - Major Products and Services
Proteome Sciences Plc - History
Proteome Sciences Plc - Company Statement
Proteome Sciences Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Proteome Sciences Plc - Business Description
Business Segment: Biomarker services and other license income
Performance
Business Segment: Grant Income
Performance
Business Segment: TMT Revenue
Performance
Geographical Segment: EU
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
Proteome Sciences Plc - SWOT Analysis
SWOT Analysis - Overview
Proteome Sciences Plc - Strengths
Proteome Sciences Plc - Weaknesses
Proteome Sciences Plc - Opportunities
Proteome Sciences Plc - Threats
Proteome Sciences Plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Proteome Sciences Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 21, 2020: Proteome Sciences : Year end trading update
Oct 31, 2019: Proteome Sciences: Trading update and announcement of Board Changes
Jan 23, 2019: Proteome Sciences: Year end trading update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Proteome Sciences Plc, Key Facts
Proteome Sciences Plc, Key Employees
Proteome Sciences Plc, Key Employee Biographies
Proteome Sciences Plc, Major Products and Services
Proteome Sciences Plc, History
Proteome Sciences Plc, Other Locations
Proteome Sciences Plc, Subsidiaries
Proteome Sciences Plc, Key Competitors
Proteome Sciences Plc, Ratios based on current share price
Proteome Sciences Plc, Annual Ratios
Proteome Sciences Plc, Annual Ratios (Cont...1)
Proteome Sciences Plc, Interim Ratios
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Proteome Sciences Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Proteome Sciences Plc, Performance Chart (2015 - 2019)
Proteome Sciences Plc, Ratio Charts
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings